The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Follow-On Biologics (aka Biosimilars, Subsequent Entry Biologics)

6 responses to “Follow-On Biologics (aka Biosimilars, Subsequent Entry Biologics)

  1. Pingback: Trends Update — Biosimilars: Sen. Kennedy, Gov. Dean and NVCA Study all Support 12+ Years of Exclusivity « The Cross-Border Biotech Blog

  2. Pingback: Trends Update — Biosimilars: The State of Play of U.S. Follow-on Biologics Legislation « The Cross-Border Biotech Blog

  3. Pingback: Top Four Biotech Trends of 2009 « The Cross-Border Biotech Blog

  4. Pingback: Biotech Trends Update: Teva’s BLA for Neupoval is Accepted at the FDA « The Cross-Border Biotech Blog

  5. Pingback: Biotech Trends at BIO 2010 « The Cross-Border Biotech Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 129 other followers